Concentrix (NASDAQ:CNXC) Given New $40.00 Price Target at Robert W. Baird

Concentrix (NASDAQ:CNXC) had its price target trimmed by Robert W. Baird from $52.00 to $40.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other research analysts have also issued reports about the company. Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Barrington Research reissued an “outperform” rating and issued a $62.00 price target on shares of Concentrix in a research note on Tuesday, March 17th. Finally, Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Concentrix presently has a consensus rating of “Hold” and an average target price of $48.50.

Concentrix Trading Down 6.8%

CNXC opened at $24.67 on Wednesday. Concentrix has a fifty-two week low of $24.27 and a fifty-two week high of $66.00. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.40. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of -1.14, a PEG ratio of 0.28 and a beta of 0.50. The company’s 50 day moving average price is $35.01 and its two-hundred day moving average price is $40.22.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.65 by ($0.04). The business had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.49 billion. Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. Concentrix’s revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.79 EPS. As a group, research analysts predict that Concentrix will post 10.11 earnings per share for the current year.

Concentrix Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 5th. Investors of record on Friday, April 24th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date of this dividend is Friday, April 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.91%.

Insider Transactions at Concentrix

In other news, CEO Christopher A. Caldwell purchased 1,000 shares of the business’s stock in a transaction on Thursday, January 29th. The shares were acquired at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. The trade was a 0.28% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Royal Bank of Canada grew its stake in Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after purchasing an additional 4,133 shares during the period. Goldman Sachs Group Inc. increased its holdings in Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after purchasing an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after buying an additional 21,746 shares during the period. Focus Partners Wealth bought a new position in shares of Concentrix during the 1st quarter worth approximately $781,000. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares in the last quarter. 90.34% of the stock is owned by institutional investors.

Concentrix News Roundup

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Revenue and business momentum — Q1 revenue rose 5.4% year-over-year and management cites strong enterprise iX Suite wins and continued AI adoption, showing demand for Concentrix’s higher-value solutions. GlobeNewswire: Q1 Results
• Positive Sentiment: Capital return actions — the company declared a $0.36 quarterly dividend (≈5.3% yield) and repurchased ~1M shares in Q1, supporting shareholder income and signaling confidence in the business. Dividend & buyback detail
• Neutral Sentiment: Company guidance maintained full-year revenue and non-GAAP EPS ranges, but Q2 guidance implies modest constant‑currency growth and lower near-term margins — investors are parsing the recovery timeline. See management’s outlook in the release. Guidance
• Neutral Sentiment: Analyst activity is mixed: several firms trimmed price targets but left buy/outperform ratings, creating dispersion in street expectations (see Benzinga summaries). Analyst PT changes
• Negative Sentiment: Margin compression and EPS miss — Q1 non-GAAP operating margin fell ~180–240 bps and GAAP EPS missed estimates; operating income and net income declined sharply (operating income down ~30%, net income down ~69%), which directly pressured the stock. Yahoo: Margin squeeze story
• Negative Sentiment: Cash-flow and leverage concerns — Q1 used cash from operations and adjusted free cash flow was negative; debt-related costs and recent early note redemption added charges. Analysts warn high leverage and negative near‑term FCF increase execution risk. QuiverQuant: cash flow & earnings detail
• Negative Sentiment: Analyst skepticism and downgrades — independent pieces and at least one downgrade argue the transition to AI-driven services is complex and costly, keeping a “hold” view until margins and cash flow recover in H2 2026. That contributed to selling pressure. Seeking Alpha: Downgrade
• Neutral Sentiment: Market data oddities — multiple short‑interest notices in feeds appear inconsistent (zero reported shares), so short‑interest signals are not reliable for today’s move. (Data sources cited in news entries.)

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.